No­var­tis pledges $100M to malar­ia ef­forts; Lil­ly, Boehringer out­lines new Jar­diance kid­ney tri­al at Ox­ford

→ No­var­tis is ded­i­cat­ing $100 mil­lion to fight malar­ia, com­mit­ting to ad­vance R&D of next-gen treat­ments ad­dress­ing re­sis­tance while al­so im­ple­ment­ing a pric­ing strat­e­gy …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER